In the context of the People's Republic of China,coronary artery disease(CAD)presents a sig-nificant clinical challenge,with over 11.3 mil-lion patients diagnosed.Traditionally,the diagnos-is of CAD has predominan...In the context of the People's Republic of China,coronary artery disease(CAD)presents a sig-nificant clinical challenge,with over 11.3 mil-lion patients diagnosed.Traditionally,the diagnos-is of CAD has predominantly relied on invasive coronary angiography.[1]However,recent advances in clinical research have revealed a notable trend:a substantial 82% of patients subjected to such invas-ive diagnostics do not necessitate interventional therapy.展开更多
It has been found that some patients with coronavirus disease 2019(COVID-19)have clinically relevant heart injuries,and the incidence of myocarditis among patients with COVID-19 was reported to be 12%in hospitals and ...It has been found that some patients with coronavirus disease 2019(COVID-19)have clinically relevant heart injuries,and the incidence of myocarditis among patients with COVID-19 was reported to be 12%in hospitals and 32%in intensive care units in Wuhan,China.[1]Acute myocardial injuries or myocarditis is a very important clinical issue due to the risk of rapid disease progression to severe arrhythmia,heart failure,cardiac shock,etc.[2,3]The bedside echocardiography examination is the first-line preferential imaging option for the evaluation of myocarditis and other complications,such as acute right heart failure specially due to pulmonary artery embolism,stress cardiomyopathy,acute myocardial infarction and coexisting fundamental chronic cardiovascular disease.展开更多
基金National Key Research and Development Program(2022YFC3602400,2023YFC2506502)Shandong Provincial Key Research and Development Program(2021SFGC0503).
文摘In the context of the People's Republic of China,coronary artery disease(CAD)presents a sig-nificant clinical challenge,with over 11.3 mil-lion patients diagnosed.Traditionally,the diagnos-is of CAD has predominantly relied on invasive coronary angiography.[1]However,recent advances in clinical research have revealed a notable trend:a substantial 82% of patients subjected to such invas-ive diagnostics do not necessitate interventional therapy.
文摘It has been found that some patients with coronavirus disease 2019(COVID-19)have clinically relevant heart injuries,and the incidence of myocarditis among patients with COVID-19 was reported to be 12%in hospitals and 32%in intensive care units in Wuhan,China.[1]Acute myocardial injuries or myocarditis is a very important clinical issue due to the risk of rapid disease progression to severe arrhythmia,heart failure,cardiac shock,etc.[2,3]The bedside echocardiography examination is the first-line preferential imaging option for the evaluation of myocarditis and other complications,such as acute right heart failure specially due to pulmonary artery embolism,stress cardiomyopathy,acute myocardial infarction and coexisting fundamental chronic cardiovascular disease.
